Brain MRI Correlations with Disease Burden and Biomarkers in Fabry Disease.
Yawen Zhao,Ying Zhu,Fan Li,Yunchuang Sun,Wei Ma,Yuan Wu,Wei Zhang,Zhaoxia Wang,Yun Yuan,Yining Huang
DOI: https://doi.org/10.1007/s00415-023-11826-8
2023-01-01
Journal of Neurology
Abstract:Objective To quantitatively evaluate cerebral small vessel disease (CSVD) in brain magnetic resonance imaging (MRI) and its correlation with disease burden and markers in Fabry disease, a rare X-linked lysosomal storage disease. Methods We collected brain MRI data from seventy-one Chinese patients with Fabry disease. CSVD was evaluated using an age-related white matter change rating scale, Fazekas scale, enlarged perivascular spaces grading scale, lacunar infarction scale, Microbleed Anatomical Rating Scale, global cortical atrophy scale, and small-vessel disease score. Factors associated with MRI lesions, including sex, clinical subtype, disease severity, disease burden, genotype, and biomarkers, were also analyzed. Results Of 71 patients, 16 (22.5%) experienced ischemic stroke. The incidences of lacunar infarctions, white matter hyperintensities, and cerebral microbleeds were 55%, 62%, and 33%, respectively. The abnormal MRI group had later disease onset, longer disease duration, and a higher Mainz Severity Score Index ( p < 0.05) than the normal MRI group. Patients with more severe clinical phenotypes also had higher CVSD-related scores. Sex and GLA mutational type were not closely associated with brain MRI lesions. Of the disease markers, the Mainz Severity Score Index and plasma globotriaosylsphingosine (Lyso-Gb 3 ) were closely correlated with the majority of the MRI scores, whereas α-galactosidase A activity was not. Conclusion Brain MRI revealed progressive lacunar infarctions, white matter hyperintensities, and decreased brain volume in patients with Fabry disease. Brain MRI lesions were closely related to onset-age; disease duration, severity, burden; and plasma Lyso-Gb 3 . However, they were not associated with sex, α-galactosidase A activity, or GLA mutation type.